On August 27, 2012, Thomas J. Baltimore, Jr. notified the Board of Directors of Integra LifeSciences Holdings Corporation (the "Company") that he was resigning as a member of the Company's Board of Directors, effective August 27, 2012. A copy of Mr. Baltimore's letter to the Board of Directors is attached as Exhibit 17.1 to this Current Report on Form 8-K and is incorporated by reference into this Item.

Following Mr. Baltimore's resignation, on August 27, 2012, the Company's Board of Directors reduced the number of members of the Board of Directors from ten
(10) to nine (9).

On August 27, 2012, the Company issued a press release announcing the resignation of Mr. Baltimore from the Company's Board of Directors and the appointment of Christian S. Schade to the Compensation Committee. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information furnished in this Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered "filed" under the Exchange Act or incorporates it by reference into a filing under the Exchange Act or the Securities Act of 1933, as amended.

(d) Exhibits

17.1    Letter, dated August 27, 2012, from Thomas J. Baltimore, Jr. to Board of
        Directors of Integra LifeSciences Holdings Corporation

99.1    Press release, dated August 27, 2012, issued by Integra LifeSciences
        Holdings Corporation